Inside the Hsp90 inhibitors binding mode through induced fit docking.

Area of Science:

• Biochemistry
• Structural Biology
• Drug Discovery

Background:

• Cancer cells exhibit genetic plasticity, leading to drug resistance.
• Heat shock protein 90 (Hsp90) is a key factor in cellular stress response and signaling pathways.
• Hsp90 inhibition is a developing anticancer therapeutic strategy, with Geldanamycin as the first identified inhibitor.

Purpose of the Study:

• To investigate Hsp90-inhibitor interactions using molecular docking.
• To explore the role of active site flexibility and water molecules in Hsp90 inhibition.
• To provide reliable models for future drug discovery efforts.

Main Methods:

• Utilized molecular docking with an induced-fit technique on Hsp90-ligand complexes.
• Analyzed eight different Hsp90-inhibitor complexes across various chemical classes.
• Accounted for active site residue flexibility and water molecule interactions.

Main Results:

• Identified conserved residues critical for Hsp90-inhibitor binding.
• Observed water molecules contributing to polar interactions within the active site.
• Generated models accurately reproduced experimental inhibitor conformations.

Conclusions:

• Induced-fit docking provides precise insights into Hsp90-inhibitor interactions.
• Conserved residues and water molecules are key targets for designing novel Hsp90 inhibitors.
• The developed models serve as valuable templates for advancing anticancer drug discovery.